{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:39:07Z","timestamp":1791225547192,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NEI Core","award":["P30EY013080"],"award-info":[{"award-number":["P30EY013080"]}]},{"DOI":"10.13039\/100000912","name":"March of Dimes","doi-asserted-by":"crossref","award":["6-FY09-281"],"award-info":[{"award-number":["6-FY09-281"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002089","name":"Fight For Sight","doi-asserted-by":"crossref","award":["FFS-PD-10-009"],"award-info":[{"award-number":["FFS-PD-10-009"]}],"id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation,","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research to Prevent Blindness, New York, NY"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.colsurfb.2013.07.039","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T08:44:46Z","timestamp":1374828286000},"page":"474-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery"],"prefix":"10.1016","volume":"112","author":[{"given":"Mallika","family":"Palamoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2013.07.039_bib0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0014-2999(02)02793-0","volume":"458","author":"Ayalasomayajula","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0015","first-page":"1929","article-title":"Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor","volume":"37","author":"Kvanta","year":"1996","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0020","unstructured":"S.E.o.l.a.r.m.d, in: D. Virgil Alfaro III, P.E. Liggett, W.F. Mieler, H. Quiroz-Mercado, R.D. Jager, Y. Tano, Age Related Macular Degeneration, Lippincot Williams & Wilkins, Philadelphia, PA, 2006, pp. 23\u201339."},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/jpet.107.128918","volume":"324","author":"Amrite","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/17425241003663236","article-title":"Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes","volume":"7","author":"Kompella","year":"2010","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems: a shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1350-9462(01)00018-0","volume":"21","author":"Ambati","year":"2002","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","article-title":"Recent advances in ophthalmic drug delivery","volume":"1","author":"Kompella","year":"2010","journal-title":"Therapeutic Delivery"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/eop.09.70","article-title":"Drug delivery to the posterior segment of the eye for pharmacologic therapy","volume":"5","author":"Shah","year":"2010","journal-title":"Expert Review of Ophthalmology"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0060","first-page":"638","article-title":"Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption","volume":"297","author":"Paulson","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2009.05.009","article-title":"Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling","volume":"73","author":"Shono","year":"2009","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0070","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W","article-title":"Organic nanoparticles in the aqueous phase\u2014theory, experiment, and use","volume":"40","author":"Horn","year":"2001","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0075","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/tf9221700457","article-title":"The solubility of small particles and the stability of colloids","volume":"17","author":"Knapp","year":"1921","journal-title":"Transactions of the Faraday Society"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/02652048.2011.552989","article-title":"Preparation and in vitro evaluation of anti-VCAM-1-Fab\u2019-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib","volume":"28","author":"Kang","year":"2011","journal-title":"Journal of Microencapsulation"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0095","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1248\/bpb.27.1993","article-title":"Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib","volume":"27","author":"Subramanian","year":"2004","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2005.02.019","volume":"511","author":"Ayalasomayajula","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijpharm.2010.04.012","article-title":"Formation of celecoxib nanoparticles from volatile microemulsions","volume":"393","author":"Margulis-Goshen","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/10611860802473402","article-title":"Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment","volume":"16","author":"Shakeel","year":"2008","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1097-4636(199802)39:2<277::AID-JBM15>3.0.CO;2-A","article-title":"Subconjunctival biocompatibility of a viscous bioerodible poly(ortho ester)","volume":"39","author":"Zignani","year":"1998","journal-title":"Journal of Biomedical Materials Research Part A"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M","article-title":"A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application","volume":"50","author":"Einmahl","year":"2000","journal-title":"Journal of Biomedical Materials Research Part A"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/ma981517m","article-title":"Erosion studies of autocatalyzed poly(ortho esters) containing lactoyl-lactyl acid dimers","volume":"32","author":"Schwach-Abdellaoui","year":"1999","journal-title":"Macromolecules"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0168-3659(99)00218-7","article-title":"Development of a poly(orthoester) prototype with a latent acid in the polymer backbone for 5-fluorouracil delivery","volume":"65","author":"Ng","year":"2000","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0135","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/bm040049n","article-title":"Poly(orthoesters)\u2014from concept to reality","volume":"5","author":"Heller","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/mp300488s","article-title":"Poly(ortho ester) nanoparticle-based targeted intraocular therapy for controlled release of hydrophilic molecules","volume":"10","author":"Palamoor","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0145","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.addr.2005.09.007","article-title":"Ocular delivery using poly(orthoesters)","volume":"57","author":"Heller","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(00)00348-5","article-title":"Release of BSA from poly(ortho ester) extruded thin strands","volume":"71","author":"Rothen-Weinhold","year":"2001","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0155","first-page":"695","article-title":"A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery","volume":"42","author":"Einmahl","year":"2001","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1163\/156856299X00432","article-title":"Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactate","volume":"10","author":"Schwach-Abdellaoui","year":"1999","journal-title":"Journal of Biomaterials Science, Polymer Edition"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfa.2005.10.064","article-title":"The effect of type of organic phase solvents on the particle size of poly(d,l-lactide-co-glycolide) nanoparticles","volume":"276","author":"Song","year":"2006","journal-title":"Colloids and Surfaces A: Physicochemical and Engineering Aspects"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0731-7085(01)00678-1","article-title":"Determination of celecoxib in pharmaceutical formulations using UV spectrophotometry and liquid chromatography","volume":"28","author":"Saha","year":"2002","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/mp800137z","article-title":"Intracellular drug delivery by poly(lactide-co-glycolic acid) nanoparticles, revisited","volume":"6","author":"Xu","year":"2009","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0180","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0169-409X(02)00055-8","article-title":"Poly(orthoester): synthesis, characterization, properties and uses","volume":"54","author":"Heller","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0185","first-page":"561","article-title":"Nanoparticles\u2014a review","volume":"5","author":"Mohanraj","year":"2006","journal-title":"Tropical Journal of Pharmaceutical Research"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2007.05.066","article-title":"Effect of the microencapsulation of nanoparticles on the reduction of burst release","volume":"344","author":"Sheikh Hasan","year":"2007","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0195","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/app.1257","article-title":"Effect of polymer compositions on the fabrication of poly(ortho-ester) microspheres for controlled release of protein","volume":"80","author":"Bai","year":"2001","journal-title":"Journal of Applied Polymer Science"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0200","series-title":"The Retinal Pigment Epithelium","article-title":"The organization of the retina and visual system","author":"Strauss","year":"1995"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle\u2013cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0210","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmanna","year":"2006","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.colsurfb.2013.07.039_bib0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2007.04.005","article-title":"Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line","volume":"567","author":"Kurejov\u00e1","year":"2007","journal-title":"European Journal of Pharmacology"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777651300475X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777651300475X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T09:30:26Z","timestamp":1539509426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777651300475X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"alternative-id":["S092777651300475X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2013.07.039","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2013.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}